Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A Novel Microplate 3D Bioprinting Platform for the Engineering of Muscle and Tendon Tissues.

Laternser S, Keller H, Leupin O, Rausch M, Graf-Hausner U, Rimann M.

SLAS Technol. 2018 Dec;23(6):599-613. doi: 10.1177/2472630318776594. Epub 2018 Jun 12.

2.

Minimal mechanical load and tissue culture conditions preserve native cell phenotype and morphology in tendon-a novel ex vivo mouse explant model.

Wunderli SL, Widmer J, Amrein N, Foolen J, Silvan U, Leupin O, Snedeker JG.

J Orthop Res. 2018 May;36(5):1383-1390. doi: 10.1002/jor.23769. Epub 2017 Nov 22.

3.

Reconstructing a hydrogen-driven microbial metabolic network in Opalinus Clay rock.

Bagnoud A, Chourey K, Hettich RL, de Bruijn I, Andersson AF, Leupin OX, Schwyn B, Bernier-Latmani R.

Nat Commun. 2016 Oct 14;7:12770. doi: 10.1038/ncomms12770.

4.

A minimalistic microbial food web in an excavated deep subsurface clay rock.

Bagnoud A, de Bruijn I, Andersson AF, Diomidis N, Leupin OX, Schwyn B, Bernier-Latmani R.

FEMS Microbiol Ecol. 2016 Jan;92(1). pii: fiv138. doi: 10.1093/femsec/fiv138. Epub 2015 Nov 4.

PMID:
26542073
5.

3D Bioprinted Muscle and Tendon Tissues for Drug Development.

Rimann M, Laternser S, Keller H, Leupin O, Graf-Hausner U.

Chimia (Aarau). 2015;69(1-2):65-7. doi: 10.2533/chimia.2015.65. No abstract available.

PMID:
26507090
6.

3D Bioprinted Muscle and Tendon Tissues for Drug Development.

Rimann M, Laternser S, Keller H, Leupin O, Graf-Hausner U.

Chimia (Aarau). 2015 Feb 25;69(1):65-67. doi: 10.2533/chimia.2015.65. No abstract available.

PMID:
28982469
7.

Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels.

Chang MK, Kramer I, Huber T, Kinzel B, Guth-Gundel S, Leupin O, Kneissel M.

Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):E5187-95. doi: 10.1073/pnas.1413828111. Epub 2014 Nov 17.

8.

Age-dependent regulation of tendon crimp structure, cell length and gap width with strain.

Legerlotz K, Dorn J, Richter J, Rausch M, Leupin O.

Acta Biomater. 2014 Oct;10(10):4447-55. doi: 10.1016/j.actbio.2014.05.029. Epub 2014 Jun 4.

9.

Comparative study of Se oxyanions retention on three argillaceous rocks: Upper Toarcian (Tournemire, France), Black Shales (Tournemire, France) and Opalinus Clay (Mont Terri, Switzerland).

Frasca B, Savoye S, Wittebroodt C, Leupin OX, Michelot JL.

J Environ Radioact. 2014 Jan;127:133-40. doi: 10.1016/j.jenvrad.2013.10.005. Epub 2013 Nov 8.

PMID:
24215888
10.

TGF-β regulates sclerostin expression via the ECR5 enhancer.

Loots GG, Keller H, Leupin O, Murugesh D, Collette NM, Genetos DC.

Bone. 2012 Mar;50(3):663-9. doi: 10.1016/j.bone.2011.11.016. Epub 2011 Dec 2.

11.

Environmental selenium research: from microscopic processes to global understanding.

Winkel LH, Johnson CA, Lenz M, Grundl T, Leupin OX, Amini M, Charlet L.

Environ Sci Technol. 2012 Jan 17;46(2):571-9. doi: 10.1021/es203434d. Epub 2011 Dec 20.

PMID:
22129299
12.

Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function.

Leupin O, Piters E, Halleux C, Hu S, Kramer I, Morvan F, Bouwmeester T, Schirle M, Bueno-Lozano M, Fuentes FJ, Itin PH, Boudin E, de Freitas F, Jennes K, Brannetti B, Charara N, Ebersbach H, Geisse S, Lu CX, Bauer A, Van Hul W, Kneissel M.

J Biol Chem. 2011 Jun 3;286(22):19489-500. doi: 10.1074/jbc.M110.190330. Epub 2011 Apr 6.

13.

Does osteocytic SOST suppression mediate PTH bone anabolism?

Kramer I, Keller H, Leupin O, Kneissel M.

Trends Endocrinol Metab. 2010 Apr;21(4):237-44. doi: 10.1016/j.tem.2009.12.002. Epub 2010 Jan 13. Review.

PMID:
20074973
14.

Bangladesh and Vietnam: different groundwater compositions require different approaches to arsenic mitigation.

Hug SJ, Leupin OX, Berg M.

Environ Sci Technol. 2008 Sep 1;42(17):6318-23. No abstract available.

PMID:
18800496
15.

Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1.

Martin-Lluesma S, Schaeffer C, Robert EI, van Breugel PC, Leupin O, Hantz O, Strubin M.

Hepatology. 2008 Nov;48(5):1467-76. doi: 10.1002/hep.22542.

PMID:
18781669
16.

Control of the SOST bone enhancer by PTH using MEF2 transcription factors.

Leupin O, Kramer I, Collette NM, Loots GG, Natt F, Kneissel M, Keller H.

J Bone Miner Res. 2007 Dec;22(12):1957-67.

17.

Arsenic removal from Bangladesh tube well water with filter columns containing zerovalent iron filings and sand.

Leupin OX, Hug SJ, Badruzzaman AB.

Environ Sci Technol. 2005 Oct 15;39(20):8032-7.

PMID:
16295871
18.

Transcriptional activation by bidirectional RNA polymerase II elongation over a silent promoter.

Leupin O, Attanasio C, Marguerat S, Tapernoux M, Antonarakis SE, Conrad B.

EMBO Rep. 2005 Oct;6(10):956-60.

19.

Oxidation and removal of arsenic (III) from aerated groundwater by filtration through sand and zero-valent iron.

Leupin OX, Hug SJ.

Water Res. 2005 May;39(9):1729-40. Epub 2005 Apr 18.

PMID:
15899271
20.
21.

Negative thymocyte selection to HERV-K18 superantigens in humans.

Meylan F, De Smedt M, Leclercq G, Plum J, Leupin O, Marguerat S, Conrad B.

Blood. 2005 Jun 1;105(11):4377-82. Epub 2005 Jan 11.

PMID:
15644416
22.
24.
25.

Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes.

Leupin O, Zaru R, Laroche T, Müller S, Valitutti S.

Curr Biol. 2000 Mar 9;10(5):277-80.

Supplemental Content

Loading ...
Support Center